Towards a subsiding diabetes epidemic: Trends from a large population-based study in Israel

Population Health Metrics

Volumn 12, Issue 1, 2014, Pages

  Karpati, Tomas ^a   Cohen Stavi, Chandra J ^a   Leibowitz, Morton ^a,b   Hoshen, Moshe ^a   Feldman, Becca S ^a   Balicer, Ran D ^a,c  

^a CLALIT HEALTH SERVICES   (Israel)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Diabetes epidemiology; Diabetes incidence; Diabetes mortality; Diabetes prevalence; Diabetes screening rates; Population at risk

Indexed keywords

DATABASE; DIABETES; DISEASE INCIDENCE; DISEASE PREVALENCE; EPIDEMIOLOGY; HEALTH CARE; HEALTH RISK; MORTALITY RISK; RISK FACTOR;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; EPIDEMIC; HIGH RISK POPULATION; HUMAN; INCIDENCE; ISRAEL; MAJOR CLINICAL STUDY; MASS SCREENING; MORTALITY RATE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; TREND STUDY; VERY ELDERLY;

ISRAEL;

EID: 84920760909     PISSN: None     EISSN: 14787954     Source Type: Journal    
DOI: 10.1186/s12963-014-0032-y     Document Type: Article

References (18)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M, on behalf of the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose): National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378:31-40.
2. Monesi L, Baviera M, Marzona I, Avanzini F, Monesi G, Nobili A, Tettamanti M, Cortesi L, Riva E, Fortino I, Bortolotti A, Fontana G, Merlino L, Roncaglioni MC: Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population-based study. Diabet Med 2012, 29:385-392.
3. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS: Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32:287-294.
4. Ringborg A, Lindgren P, Martinell M, Yin DD, Schon S, Stalhammar J: Prevalence and incidence of Type 2 diabetes and its complications 1996-2003-estimates from a Swedish population-based study. Diabet Med 2008, 25:1178-1186.
5. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K: The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 2008, 51:2187-2196.
6. Lipscombe LL, Hux JE: Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 2007, 369:750-756.
7. Gonzalez EL, Johansson S, Wallander MA, Rodriguez LA: Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009, 63:332-336.
8. Holden SH, Barnett AH, Peters JR, Jenkins-Jones S, Poole CD, Morgan CL, Currie CJ: The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab 2013, 15:844-852.
9. Centers for Disease Control and Prevention: National diabetes fact sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta: U.S: Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
10. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF: Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010, 8:29.
11. van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B: The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil 2010, 17(Suppl 1):S3-S8.
12. Desai JR, Wu P, Nichols GA, Lieu TA, O'Connor PJ: Diabetes and asthma case identification, validation, and representativeness when using electronic health data to construct registries for comparative effectiveness and epidemiologic research. Med Care 2012, 50(Suppl):S30-S35.
13. Das KP, Schurer W: Diabetes expenditure, burden of disease and management in 5 EU countries. London: LSE Health, London School of Economics; 2012. i-113.
14. Lin CC, Li CI, Hsiao CY, Liu CS, Yang SY, Lee CC, Li TC: Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study. BMC Public Health 2013, 13:318.
15. Hamer M, Kengne AP, Batty GD, Cooke D, Stamatakis E: Temporal trends in diabetes prevalence and key diabetes risk factors in Scotland, 2003-2008. Diabet Med 2011, 28:595-598.
16. Shmueli A, Bendelac J, Achdut L: Who switches sickness funds in Israel? Health Econ Policy Law 2007, 2:251-265.
17. Cohen R: Sick Fund Membership. In Periodic Surveys. Jerusalem: The National Insurance Institute; 2013.
18. American Diabetes Association: Standards of Medical Care in Diabetes-2013. Diabetes Care 2013, 36(Suppl):S11-S66.